How can I calculate my SIP returns in Nippon India Pharma Fund Direct-Growth?
The SIP Returns Calculator on the Calculators tab lets you simulate any monthly SIP amount in Nippon India Pharma Fund Direct-Growth over any period within its NAV history (Equity: Sectoral-Pharma category). It uses actual historical NAV data — not assumed returns — and shows total invested amount, current corpus value and absolute return. As a reference, Nippon India Pharma Fund Direct-Growth has delivered a since-inception CAGR of 17.68%.
What would a monthly SIP of ₹ 500 in Nippon India Pharma Fund Direct-Growth have returned?
Using the SIP Returns Calculator, you can compute the exact corpus created by a ₹ 500 per month SIP in Nippon India Pharma Fund Direct-Growth over any historical period. The result shows your invested amount, current value and absolute return using real NAV data. At the fund's since-inception CAGR of 17.68%, a ₹ 500 monthly SIP over 10 years would have grown to approximately ₹ NaN L (indicative, not guaranteed). Use the Calculators tab for the exact historical figure.
What is the lumpsum return calculator for Nippon India Pharma Fund Direct-Growth?
The Rolling Returns Calculator in the Calculators tab shows the CAGR of a lumpsum investment in Nippon India Pharma Fund Direct-Growth for all possible start dates over a chosen holding period. It displays the best, worst and median CAGR so you can see the range of outcomes rather than a single point-in-time number. Nippon India Pharma Fund Direct-Growth's since-inception CAGR is 17.68%. The maximum historical drawdown has been -0.24% — useful context for understanding downside risk.
What is a SWP (Systematic Withdrawal Plan) and how does it work for Nippon India Pharma Fund Direct-Growth?
A SWP lets you withdraw a fixed monthly amount from Nippon India Pharma Fund Direct-Growth while keeping the remaining units invested and compounding (fund AUM: ₹ 9.04 k Cr). The SWP Calculator in the Calculators tab lets you set an initial lumpsum, a monthly withdrawal amount and a duration to estimate how long the corpus lasts and what the final value would be. With a since-inception CAGR of 17.68%, the fund can sustain withdrawals when the withdrawal rate is lower than the fund's return rate.
What are the rolling returns of Nippon India Pharma Fund Direct-Growth for a 5-year SIP?
The Rolling Returns Calculator in the Calculators tab shows SIP returns for Nippon India Pharma Fund Direct-Growth across 1Y, 3Y, 5Y, 7Y and 10Y holding periods using every possible start date in the fund's history. This reveals the best, median and worst SIP outcomes — far more informative than a single trailing return figure. Nippon India Pharma Fund Direct-Growth's Sharpe ratio of 1.00 reflects its historical risk-adjusted efficiency. Since-inception CAGR: 17.68%.
How much do I need to invest monthly in Nippon India Pharma Fund Direct-Growth to build a corpus of ₹1 crore?
Based on Nippon India Pharma Fund Direct-Growth's since-inception CAGR of 17.68%, an estimated monthly SIP of ₹ 30,400 over 10 years or ₹ 11,300 over 15 years could build a ₹1 crore corpus (indicative — past returns do not guarantee future performance). Use the SIP Returns Calculator to simulate with different return assumptions and time horizons.
What is the difference between SIP and lumpsum investing in Nippon India Pharma Fund Direct-Growth?
A SIP in Nippon India Pharma Fund Direct-Growth invests a fixed amount (minimum ₹ 500) every month, averaging the purchase NAV over time and reducing market timing risk — especially beneficial in a volatile category like Equity: Sectoral-Pharma. A lumpsum invests the full amount at once — it outperforms SIP in strong uninterrupted bull markets but carries higher timing risk. Nippon India Pharma Fund Direct-Growth has seen a max drawdown of -0.24%, illustrating the timing risk a lumpsum investor faces. Both approaches can be simulated in the Calculators tab.
How does the rolling returns calculator differ from trailing returns for Nippon India Pharma Fund Direct-Growth?
Trailing returns for Nippon India Pharma Fund Direct-Growth are fixed to a single end date — today — and measured backwards over 1Y, 3Y, 5Y etc. They can be misleading if today happens to be a market peak or trough. Rolling returns, by contrast, show performance across every possible investment window of the chosen length within Nippon India Pharma Fund Direct-Growth's history. For reference, Nippon India Pharma Fund Direct-Growth's since-inception CAGR is 17.68%. Rolling returns are in the Rolling Returns section of the Performance tab; the rolling SIP calculator is in the Calculators tab.
What is the impact of expense ratio on my SIP returns in Nippon India Pharma Fund Direct-Growth?
Nippon India Pharma Fund Direct-Growth has an expense ratio of 1.00%. The expense ratio is deducted daily from the NAV and is already baked into all historical return figures shown in the Calculators tab. Over a 20-year investment, a 1% higher expense ratio reduces the final corpus by roughly 18–22%. This makes Direct plan selection critical — it directly adds to your compounding NAV.
Are the SIP return calculations based on actual NAV data for Nippon India Pharma Fund Direct-Growth?
Yes — all calculators use Nippon India Pharma Fund Direct-Growth's actual historical NAV data (current NAV: ₹ 631.7600). This makes results far more accurate than generic calculators that assume a fixed 12% or 15% annual return. Nippon India Pharma Fund Direct-Growth's actual since-inception CAGR is 17.68% with a maximum drawdown of -0.24% — real figures that capture both the upside and the volatility experienced by actual investors.
